Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Oulogram
- Development stage
- Unknown
- Lead developer
- NI-THE
- Modality
- Small Molecules
- Administration
- Buccal
01
Overview
**Oulogram** is an approved NI-THE oral antiseptic fixed-dose combination containing sodium borate, tannic acid, thymol, and tyrothricin for oral infections. Its local antimicrobial activity is principally supported by tyrothricin, a polypeptide antibiotic mixture with membrane-disrupting activity against susceptible bacteria, together with the antiseptic properties of thymol and sodium borate; tannic acid provides local astringent activity. NI-THE identifies Oulogram as a dental product and lists the product composition as tyrothricine, thymol, tannine, and sodium borate. ([ni-the.com](https://ni-the.com/en/))
- Brand names
- Oulogram
- Other names
- borax + tannic acid + thymol + tyrothricin
Beyond the preview
Go deeper on Oulogram.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Oulogram.